Steven Licon - 1933 Industries Sr Operations
| TGIFF Stock | USD 0 0 26.92% |
Insider
Steven Licon is Sr Operations of 1933 Industries
| Phone | 604 674 4756 |
| Web | https://www.1933industries.com |
1933 Industries Management Efficiency
The company has return on total asset (ROA) of (0.0974) % which means that it has lost $0.0974 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.1636) %, meaning that it generated substantial loss on money invested by shareholders. 1933 Industries' management efficiency ratios could be used to measure how well 1933 Industries manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jared Stanley | Charlottes Web Holdings | 35 | |
| Thomas Hemingway | BioQuest Corp | 66 | |
| Joseph JD | Centr Brands Corp | 56 | |
| Dina Rollman | Green Thumb Industries | 50 | |
| CA CBV | Tilray Inc | 52 | |
| Perry Antelman | Charlottes Web Holdings | 59 | |
| Mathew Faulkner | Green Thumb Industries | 50 | |
| Bernard Yeung | Tilray Inc | N/A | |
| Greg Gould | Charlottes Web Holdings | N/A | |
| Bret Kravitz | Green Thumb Industries | 43 | |
| David Spence | HLS Therapeutics | 55 | |
| David Young | Centr Brands Corp | 42 | |
| Tim Orr | Charlottes Web Holdings | N/A | |
| James Meiers | Tilray Inc | 66 | |
| Victoria Covel | Sonoma Pharmaceuticals | N/A | |
| Linda Marsicano | Green Thumb Industries | 55 | |
| James DVM | Durect | 67 | |
| Gilbert Godin | HLS Therapeutics | 64 | |
| Kelly Shea | Charlottes Web Holdings | N/A | |
| Francois Lafortune | Crescita Therapeutics | N/A | |
| Dominic KingSmith | Crescita Therapeutics | N/A | |
Management Performance
| Return On Equity | -1.16 | |||
| Return On Asset | -0.0974 |
1933 Industries Leadership Team
Elected by the shareholders, the 1933 Industries' board of directors comprises two types of representatives: 1933 Industries inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 1933. The board's role is to monitor 1933 Industries' management team and ensure that shareholders' interests are well served. 1933 Industries' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, 1933 Industries' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brent Hilton, Controller | ||
| Ester Vigil, Director Sales | ||
| Alexia Helgason, VP Communication | ||
| Marion McGrath, Company Sec | ||
| Paul LLB, CEO Chairman | ||
| Caleb Zobrist, Exec Counsel | ||
| Steven Licon, Sr Operations |
1933 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is 1933 Industries a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.16 | |||
| Return On Asset | -0.0974 | |||
| Profit Margin | (1.14) % | |||
| Operating Margin | (0.37) % | |||
| Current Valuation | 19.37 M | |||
| Shares Outstanding | 454.2 M | |||
| Shares Owned By Insiders | 7.53 % | |||
| Shares Owned By Institutions | 0.21 % | |||
| Price To Book | 0.94 X | |||
| Price To Sales | 0.44 X |
Currently Active Assets on Macroaxis
Other Information on Investing in 1933 OTC Stock
1933 Industries financial ratios help investors to determine whether 1933 OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 1933 with respect to the benefits of owning 1933 Industries security.